Sign In    Register

World Journal of Emergency Medicine ›› 2013, Vol. 4 ›› Issue (3): 169-174.doi: 10.5847/wjem.j.issn.1920-8642.2013.03.002

• Review Articles • Previous Articles     Next Articles

The Acinetobacter baumannii group:a systemic review

Hua-zhong Zhang, Jin-song Zhang(), Li Qiao   

  1. Department of Emergency Medicine, First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China
  • Received:2013-02-15 Accepted:2013-06-21 Online:2013-09-15 Published:2013-09-15
  • Contact: Jin-song Zhang


BACKGROUND: The Acinetobacter baumannii group, includingAcinetobacter baumannii, Acinetobacter genomospecies 3 and 13TU, is phenotypically indistinguishable and uniformly identified as Acinetobacter baumannii by laboratories of clinical microbiology. This review aimed to demonstrate the differences among them.
METHODS: Literatures associated with the Acinetobacter baumannii group were identified and selected from PubMed databases and relevant journals.
RESULTS: Acinetobacter genospecies 3 and 13TU possess a certain proportion in clinical isolates. There were considerable differences in epidemiologic features, clinical manifestations, antimicrobial resistances and therapeutic options among the Acinetobacter baumannii group. Compared with Acinetobacter genomospecies 3 and 13TU, Acinetobacter baumannii with a higher resistance to antimicrobial agents are easier to be treated inappropriately, and present a worse outcome in patients.
CONCLUSION: The Acinetobacter baumannii group comprises three distinct clinical entities, and their clinical value are not equal.

Key words: Acinetobacter baumannii, Acinetobacter genomospecies 3, Acinetobacter genomospecies 13TU, Difference